Director Share Dealings
September 30, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
announces that today Ordinary Shares ("Shares") and American Depository Shares
("ADSs") of the Company, as set out below, have been acquired for the
Non-Executive Directors, being the part of their total fees that are paid in
shares for the period of service from July 1 to September 30, 2014.
Type of Security(1) Number of Shares/ADSs
Dominic Blakemore Shares 98
William Burns Shares 99
Dr. Steven Gillis ADSs 32
Dr. David Ginsburg ADSs 30
David Kappler Shares 104
Susan Kilsby ADSs 100
Anne Minto Shares 104
David Stout ADSs 32
(1) One ADS is equal to three Shares
The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ
respectively at prices of £53.45 per Share and $259.9747 per ADS.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
Investor Relations
Jeff Poulton jpoulton@shire.com +1 781 482 0945
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
Media
Stephanie Fagan sfagan@shire.com +1 781 482 0460
Gwen Fisher gfisher@shire.com +1 484 595 9836
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases,
Gastrointestinal, and Internal Medicine and we are developing treatments for
symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas, such as Ophthalmology.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
Press Release
www.shire.com
distributed by
 | |
SHIRE 
